These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18622272)

  • 1. Randomization is essential for progress in transplant medicine.
    Baigent C; Emberson JR
    Transplantation; 2008 Jul; 86(1):26-7. PubMed ID: 18622272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data.
    Craig JC; Webster AC; Mitchell A; Irwig L
    Transplantation; 2008 Jul; 86(1):32-5. PubMed ID: 18622275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence in transplantation: randomized versus nonrandomized studies.
    Morris PJ; Monaco AP
    Transplantation; 2008 Jul; 86(1):16-7. PubMed ID: 18622270
    [No Abstract]   [Full Text] [Related]  

  • 4. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.
    Takemoto SK; Arns W; Bunnapradist S; Garrison LP; Guirado L; Kalo Z; Oniscu G; Opelz G; Scolari MP; Stefoni S; Yaqoob M; Brennan DC
    Transplantation; 2008 Jul; 86(1):18-25. PubMed ID: 18622271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementarity comes of age.
    Black N
    Transplantation; 2008 Jul; 86(1):28-9. PubMed ID: 18622273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the evidence base in transplantation: toward a balanced approach.
    van der Meulen J
    Transplantation; 2008 Jul; 86(1):30-1. PubMed ID: 18622274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody induction therapy for lung transplant recipients.
    Penninga L; Møller CH; Penninga EI; Iversen M; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008927. PubMed ID: 24282128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens.
    Hathaway D; Winsett R; Prendergast M; Subaiya I
    Clin Transplant; 2003 Jun; 17(3):183-94. PubMed ID: 12780666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registry of randomized controlled trials in transplantation: January 1 to June 30, 2006.
    Pengel L; Barcena L; Morris PJ
    Transplantation; 2007 Apr; 83(8):1001-14. PubMed ID: 17452884
    [No Abstract]   [Full Text] [Related]  

  • 11. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Gulati R; McGrory CH; Coscia LA
    Clin Transpl; 2005; ():69-83. PubMed ID: 17424726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [To further improve transplantation results].
    Chirurg; 2002 Dec; 73(12):2 p following M392. PubMed ID: 12599314
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.
    Rezahosseini O; Møller DL; Knudsen AD; Sørensen SS; Perch M; Gustafsson F; Rasmussen A; Ostrowski SR; Nielsen SD
    Front Immunol; 2020; 11():567715. PubMed ID: 33178194
    [No Abstract]   [Full Text] [Related]  

  • 15. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
    Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
    Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis.
    Howell M; Wong G; Turner RM; Tan HT; Tong A; Craig JC; Howard K
    Am J Kidney Dis; 2016 May; 67(5):762-74. PubMed ID: 26724168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive regimens in lung transplant recipients.
    Bhorade SM; Villanueva J; Jordan A; Garrity ER
    Drugs Today (Barc); 2004 Dec; 40(12):1003-12. PubMed ID: 15645011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.